Handelsbanken Fonder AB »

Intellia Therapeutics shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2023-12-31 $579k 19k 30.47
2023-09-30 $430k 14k 31.62
2023-06-30 $555k 14k 40.81
2023-03-31 $403k 11k 37.31
2022-12-31 $377k 11k 34.91
2022-09-30 $532k 9.5k 56.00
2022-06-30 $492k 9.5k 51.79
2022-03-31 $690k 9.5k 72.63
2021-12-31 $1.3M 11k 118.25
2021-09-30 $1.9M 14k 134.14
2021-03-31 $827k 10k 80.29
2020-12-31 $533k 9.8k 54.39